---

$5.55

-0.0050 ( -0.09% ) 0.1K

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-12-18	Sale	-187582.00	Alam Kamran
2023-12-18	Sale	-334005.00	Nagendran Sukumar
2023-12-18	Sale	-466550.00	Nolan Sean P.
2023-11-20	Buy	100000.00	Manning Paul B
2023-11-03	Sale	-43800.00	Long Alison S
2023-08-25	Sale	-33000.00	Alam Kamran
2023-08-16	Buy	16466667.00	Manning Paul B
2023-08-16	Buy	388889.00	Stalfort John A III
2023-08-16	Buy	444444.00	Nolan Sean P.
2023-08-16	Buy	111111.00	Donenberg Phillip B.